These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10853393)
21. Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem? Colebunders R; Florence E; Ostyn B Int J Infect Dis; 2001; 5(4):234; author reply 234-5. PubMed ID: 11962349 [No Abstract] [Full Text] [Related]
22. The continuing evolution of HIV therapy. Boyle BA AIDS Read; 2003 Dec; 13(12):576-8, 582. PubMed ID: 14959692 [No Abstract] [Full Text] [Related]
23. Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide. Vila J; Nugier F; Barguès G; Vallet T; Peyramond D; Hamedi-Sangsari F; Seigneurin JM Lancet; 1997 Aug; 350(9078):635-6. PubMed ID: 9288048 [No Abstract] [Full Text] [Related]
24. Long-term suppression of HIV-1 by hydroxyurea and didanosine. Lori F; Jessen H; Foli A; Lisziewicz J; Matteo PS JAMA; 1997 May; 277(18):1437-8. PubMed ID: 9145714 [No Abstract] [Full Text] [Related]
25. Is Hydroxyurea for real? Mascolini M J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):6-16, 18. PubMed ID: 11365731 [TBL] [Abstract][Full Text] [Related]
28. [Antiretroviral therapy. Current status and perspectives]. Lüthy R Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223 [No Abstract] [Full Text] [Related]
29. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944 [TBL] [Abstract][Full Text] [Related]
35. HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor. Lisziewicz J; Jessen H; Finzi D; Siliciano RF; Lori F Lancet; 1998 Jul; 352(9123):199-200. PubMed ID: 9683211 [No Abstract] [Full Text] [Related]
36. Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters. Lori F; Rosenberg E; Lieberman J; Foli A; Maserati R; Seminari E; Alberici F; Walker B; Lisziewicz J AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1333-8. PubMed ID: 10515148 [TBL] [Abstract][Full Text] [Related]